New Journey Health Technology Group Co.,LTD
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | New Mileage Health Technology Group Co., Ltd. (referred to as "New Mileage Co., Ltd.", securities code: 002219) is an A-share listed company controlled by New Mileage Health Group Co., Ltd. (referred to as "New Mileage Health Group"). New Mileage Co., Ltd., formerly known as Hengkang Medical Group Co., Ltd., entered the A-share market in March 2008. Originally a manufacturer of traditional Chinese medicine, it acquired its first hospital in January 2013 and began entering the medical industry. It has now become a medical and health industry group covering medical services, drug manufacturing, and other business areas. In the field of medical services, New Mileage Co., Ltd. promotes the layout of medical institutions with regional medical centers as the strategy, and creates a "1+N" innovative service model based on Class III comprehensive hospitals and "comprehensive hospitals+specialized branches", focusing on aging diseases such as tumors, cardiovascular diseases, cerebrovascular diseases, and orthopedics. At present, New Mileage Co., Ltd. has established five major regional medical centers in Liaoning, Henan, Jiangsu, Jiangxi, and Sichuan, with four tertiary hospitals and seven second-class hospitals, with over ten thousand beds. In the field of drug manufacturing, New Mileage Co., Ltd. takes drug manufacturing as the basic industry, and has a series of traditional Chinese patent medicines and simple preparations, chemical drugs and biomacromolecule drugs with the "unique" brand as the core. Duyiwei Pharmaceutical is a well-known trademark in China with 36 national batch numbers. New Mileage Co., Ltd. adheres to the mission of "providing better health services for everyone" and will continuously invest in technology, talent, funds, and resources to build its affiliated hospitals into leading medical service institutions in the region, forming a competitive medical brand; Using "Uni Flavor" as a platform, integrate upstream and downstream industry chains, layout healthy consumer products, integrate high-quality peers, etc., expand and strengthen the traditional Chinese medicine sector, and achieve brand innovation and connotation upgrading. |
| Headquarter | Longnan |
| Establish Date | 9/30/2001 |
| Listed Code | 002219.SZ |
| Listed Date | 3/6/2008 |
| Chairman | Lin Yanglin. |
| CEO | |
| Website | www.njhtg.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
